Functional p75 interleukin‐2 receptor expression on the fresh blast cells in childhood acute lymphoblastic leukemia with natural killer cell properties
- 1 April 1991
- journal article
- case report
- Published by Wiley in American Journal of Hematology
- Vol. 36 (4) , 259-264
- https://doi.org/10.1002/ajh.2830360407
Abstract
Neoplastic cells of childhood acute lymphoblastic leukemia (ALL) with natural killer (NK) cell properties were studied for the expression of p75 interleukin‐2 receptors (IL‐2R) and the receptor functions. Freshly prepared blast cells from a patient with ALL had NK cell properties: (1) the phenotype such as CD56+, CD2+, E‐rosette+, CD3−, and CD19−; and (2) the presence of spontaneous cytotoxicity against NK‐sensitive K562 target cells. Although p55 Tac antigen was not detectable, there was the expression of p75 IL‐2R on the freshly prepared blast cells: 70% of the cells reacted with Mik‐β1 monoclonal antibody against p75 IL‐2R as determined by flow cytometry. Two‐color flow cytometry revealed that the blast cells expressed both p75 IL‐2R and NKH‐1. NK activity of the blast cells was augmented by their treatment with 1,000 U/ml recombinant IL‐2 (rIL‐2): the cytotoxicity level as percentage lysis increased to 38.7% from 22.0% when the normal lymphocyte value increased to 62.1% from 46.2%. Although the blast cells possessed no apparent level of proliferative capacity, the addition of 1,000 U/ml rlL‐2 yielded a 2.7‐fold increase in their thymidine uptake. These results demonstrate the expression of functional p75 IL‐2R on the patient's blast cells with NK cell properties.Keywords
This publication has 25 references indexed in Scilit:
- Biology of Natural Killer CellsPublished by Elsevier ,2008
- Natural killer cells in children with acute leukemia. The effect of interleukin-2Cancer, 1987
- The IL-2 Receptor β Chain (p70): Role in Mediating Signals for LAK, NK, and Proliferative ActivitiesScience, 1987
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- Interleukin 2 high-affinity receptor expression requires two distinct binding proteins.The Journal of Experimental Medicine, 1987
- Novel Interleukin-2 Receptor Subunit Detected by Cross-Linking Under High-Affinity ConditionsScience, 1986
- Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.The Journal of Experimental Medicine, 1982
- Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative GroupBritish Journal of Haematology, 1976
- Lymphocyte membrane receptors in human lymphoid leukemiasEuropean Journal of Immunology, 1975
- An improved rosetting assay for detection of human T lymphocytesJournal of Immunological Methods, 1974